TSE:LEAF - MedReleaf Stock Price, News, & Analysis

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume758,400 shs
Average Volume729,112 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive LEAF News and Ratings via Email

Sign-up to receive the latest news and ratings for LEAF and its competitors with MarketBeat's FREE daily newsletter.

MedReleaf (TSE:LEAF) Frequently Asked Questions

What is MedReleaf's stock symbol?

MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."

Has MedReleaf been receiving favorable news coverage?

News articles about LEAF stock have trended somewhat positive on Monday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MedReleaf earned a news impact score of 1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for MedReleaf.

Who are some of MedReleaf's key competitors?

What other stocks do shareholders of MedReleaf own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MedReleaf investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aurora Cannabis (ACB), GW Pharmaceuticals PLC- (GWPH), Canopy Growth (CGC), Aurora Cannabis (ACBFF), Cronos Group (CRON), CannTrust (CTST), Energous (WATT) and OrganiGram (OGI).

Who are MedReleaf's key executives?

MedReleaf's management team includes the folowing people:
  • Mr. Neil J. Closner, CEO, Co-Founder & Director
  • Mr. Igor Gimelshtein, CFO & Corp. Sec.
  • Mr. Donald Courtney, Chief Operating Officer
  • Ms. Christie Hall, VP of Fin. & Accounting
  • Dr. Jeremy N. Friedberg, Chief Science Officer

How do I buy shares of MedReleaf?

Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is MedReleaf's official website?

The official website for MedReleaf is http://medreleaf.com/.


MarketBeat Community Rating for MedReleaf (TSE LEAF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  309
MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe LEAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LEAF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel